These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 613782)

  • 21. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
    Wahl DG; Simon JP; Robin B; Walker P; Jouanny P; Escanye JM; Paille F; Schmidt C; Brunotte F; Robert J
    Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
    Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
    Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measurement of muscle oxygen pressure in healthy subjects and patients with arterial occlusive disease].
    Creutzig A
    Fortschr Med; 1985 Jul; 103(26):694-6. PubMed ID: 4043899
    [No Abstract]   [Full Text] [Related]  

  • 26. Muscle tissue oxygen pressure in patients with arterial occlusive disease.
    Creutzig A; Wrabetz W; Lux M; Alexander K
    Microvasc Res; 1985 May; 29(3):350-9. PubMed ID: 3158800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic changes in the legs during treadmill exercise with and without arterial occlusive disease].
    Maass U; Konrad H; Fröhlich H; Alexander K
    Vasa; 1982; 11(1):9-14. PubMed ID: 7064526
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Effect of arterial reconstructive surgery.
    Holm J; Dahllöf AG; Scherstén T
    Scand J Clin Lab Invest; 1975 Jan; 35(1):81-6. PubMed ID: 1129595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
    Rudofsky G; Brock FE; Ulrich M; Nobbe F
    Med Klin; 1979 Jul; 74(28-29):1093-6. PubMed ID: 556192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Improvement of nutritive blood flow in peripheral ischemic diseases. Experimental bases-clinico-therapeutic possibilities --assessment of effects].
    Ehrly AM
    Vasa Suppl; 1983; 11():1-21. PubMed ID: 6349163
    [No Abstract]   [Full Text] [Related]  

  • 32. Exercise-induced variations in muscle tissue oxygen pressure in claudicants: effects of buflomedil.
    Ehrly AM; Saeger-Lorenz K
    Blood Vessels; 1991; 28 Suppl 1():27-32. PubMed ID: 1932764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vivo 31-phosphorus MR spectroscopy of the calf musculature in arterial occlusive diseases].
    Melchert UH; Brinkmann G; Förger K; Gleim M; Wunsch-Binder F; Maier C; Zick G
    Rofo; 1992 Apr; 156(4):346-52. PubMed ID: 1571516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One hundred percent oxygen reverses muscle hypoxia in a rat hindlimb model of acute arterial occlusion.
    Schroder WB; Wilkerson DK; Zatina MA
    J Vasc Surg; 1990 Dec; 12(6):667-74; discussion 674-5. PubMed ID: 2243403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent claudication--pathophysiological considerations.
    Vanhoutte PM; De Mey C; Wellens D
    Acta Cardiol; 1979; 34(3):125-32. PubMed ID: 315681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle high energy phosphates in chronic peripheral vascular disease.
    Todd GJ; Van de Wiele B; Askanazi J; Yoshikawa K; Elwyn DH; Kinney JM; Reemtsma K
    J Surg Res; 1988 Mar; 44(3):277-83. PubMed ID: 3343825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced alterations in muscle tissue oxygen pressure in patients with arterial occlusive disease.
    Creutzig A; Alexander K
    Int J Microcirc Clin Exp; 1985; 4(2):173-81. PubMed ID: 2412983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
    Heidrich H
    ZFA (Stuttgart); 1981 Apr; 57(10):742-50. PubMed ID: 6165157
    [No Abstract]   [Full Text] [Related]  

  • 39. [Physiopathological and pathogenic aspects of intermittent claudication].
    Cospite M; Ferrara F
    Angiologia; 1984; 36(6):283-8. PubMed ID: 6517387
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic studies of muscles and blood in ergometrically stressed patients with arterial occlusive disease].
    Nissen P; Alexander K; Maass U
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():176. PubMed ID: 613562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.